These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 10220509
1. Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites. Bosch-Marcè M, Clària J, Titos E, Masferrer JL, Altuna R, Poo JL, Jiménez W, Arroyo V, Rivera F, Rodés J. Gastroenterology; 1999 May; 116(5):1167-75. PubMed ID: 10220509 [Abstract] [Full Text] [Related]
7. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient]. Galli G, Panzetta G. G Ital Nefrol; 2002 Sep; 19(2):199-203. PubMed ID: 12195419 [Abstract] [Full Text] [Related]
8. Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats. Richter CM, Godes M, Wagner C, Maser-Gluth C, Herzfeld S, Dorn M, Priem F, Slowinski T, Bauer C, Schneider W, Neumayer HH, Kurtz A, Hocher B. J Hypertens; 2004 Jan; 22(1):191-8. PubMed ID: 15106811 [Abstract] [Full Text] [Related]
17. Effect of cyclooxygenase-2 inhibition on renal function after renal ablation. Sanchez PL, Salgado LM, Ferreri NR, Escalante B. Hypertension; 1999 Oct; 34(4 Pt 2):848-53. PubMed ID: 10523372 [Abstract] [Full Text] [Related]
18. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS. Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374 [Abstract] [Full Text] [Related]
19. Effects of lysine clonixinate and ketorolac tromethamine on prostanoid release from various rat organs incubated ex vivo. Pallapies D, Salinger A, Meyer zum Gottesberge A, Atkins DJ, Rohleder G, Nagyiványi P, Peskar BA. Life Sci; 1995 Jan 01; 57(2):83-9. PubMed ID: 7603299 [Abstract] [Full Text] [Related]
20. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M. Clin Pharmacol Ther; 1999 Jul 01; 66(1):76-84. PubMed ID: 10430112 [Abstract] [Full Text] [Related] Page: [Next] [New Search]